alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# United States Court of Appeals **For the Eighth Circuit**

___________________________ No. 16-1469

___________________________ United States of America lllllllllllllllllllllPlaintiff - Appellee v. Markeith Deshun Thomas lllllllllllllllllllll Defendant - Appellant

____________ Appeal from United States District Court for the Eastern District of Arkansas - Little Rock

____________ Submitted: August 2, 2016 Filed: August 8, 2016 [Unpublished]

____________ Before LOKEN, BENTON, and KELLY, Circuit Judges.

____________ PER CURIAM. Markeith Deshun Thomas directly app eals the sentence imposed by the district court 1 after he pled guilty to possessing and selling stolen firearms in violation of 18
1 The Honorable J. Leon Holmes, United States District Judge for the Eastern District of Arkansas.U.S.C. §§ 922(j) and 924(a)(2). His counsel has moved to withdraw and filed a brief under Anders v. California , 386 U.S. 738 (1967). Having jurisdiction under 28 U.S.C. § 1291, this court dismisses the appeal. Thomas’s appeal waiver should be enfor ced and prevents consideration of his claim. See United States v. Scott , 627 F.3d 702, 704 (8th Cir. 2010) (de novo review of validity and applicability of appeal waiver); United States v. Andis , 333 F.3d 886, 889-90 (8th Cir. 2003) (en banc) (court should enforce appeal waiver and dismiss appeal where it falls within scope of waiv er, plea agreement and waiver were entered into knowingly and voluntarily, and no miscarriage of justice would result). An independent review of the record under Penson v. Ohio , 488 U.S. 75 (1988), reveals no non-frivolous issues for appeal. The appeal is dismissed and counsel’s motion to withdraw is granted.

______________________________

-2-
Exhibit 21.1



|                                         |  |                 
|---------------------------------------- |  | ----------------
|Subsidiary                               |  | Jurisdiction    
|                                         | 
|ROVCAL, Inc.                             |  | USA (California)
|                                         | 
|ROV Holding, Inc.                        |  | USA (Delaware)  
|                                         | 
|Rayovac (UK) Limited                     |  | United Kingdom  
|                                         | 
|Spectrum Brands Lux S.A.R.L              |  | Luxembourg      
|                                         | 
|Tetra Holding GmbH                       |  | Germany         
|                                         | 
|Rayovac Europe GmbH                      |  | Germany         
|                                         | 
|VARTA Consumer Batteries GmbH & Co. KGaA |  | Germany         
|                                         | 
|United Industries Corporation            |  | USA (Delaware)  
|                                         | 
|United Pet Group, Inc.                   |  | USA (Delaware)
EXHIBIT 31.2  CERTIFICATION OF CHIEF FINANCIAL OFFICER  I, Olga Malitski, certify that:  1.   I have reviewed this report on Form 10-Q of Nature of Beauty Ltd.  2.   based on my knowledge, this report does not contain any untrue statement of a material fact omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;  3.   Based on my knowledge, the financial statements and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of and for, the period presented in this report;  4.   I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act rules 13a-15(e) and15d-15(e)) for the registrant and have:  a.   designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; b.   designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; c.   evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and d.   disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter( the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and  5.   I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):  a.   all significant deficiencies and material weakness in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and b.   any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.  IN WITNESS WHEREOF, the undersigned has executed this certification as of the 12th day of November, 2008.   /s/ Olga Malitski _________________________________ Name:  Olga Malitski Title: Chief Financial Officer
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Nursing Research Initial Review Group.                    

*Date:*                         February 28-29, 2008.                    

*Time:*                         8 a.m. to 5 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, MD 20814.                    

*Contact Person:*                         Yujing Liu, PHD, MD, Chief, Office of Review, National Institute of Nursing Research, National Institutes of Health, 6707 Democracy Blvd., Ste. 710, Bethesda, MD 20892, (301) 594-3169,                         *yujing_liu@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.361, Nursing Research, National Institutes of Health, HHS)

Dated: January 30, 2008.

Jennifer Spaeth,

Director, Office of Federal Advisory Committee Policy.

[FR Doc. 08-503  Filed 2-5-08; 8:45 am]

BILLING CODE 4140-01-M
Exhibit 32.01 and Exhibit 32.02  CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002  I, Denny W. Nestripke, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 that the Quarterly Report of Millstream Ventures, Inc. on Form 10-Q for the period ended June 30, 2008:  1. Fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, and  2. The information contained in such Form 10-Q fairly presents in all material respects the financial condition and results of operations of Millstream Ventures, Inc.     By: /s/ Denny W. Nestripke  Name: Denny W. Nestripke Title: Chief Executive Officer and Chief Financial Officer Date: July 10, 2008   A signed original of this written statement required by Section 906 of the Sarbanes-Oxley Act of 2002 has been provided to the small business issuer and will be retained by the small business issuer and furnished to the Securities and Exchange Commission or its staff upon request.
EXHIBIT 32.1






CERTIFICATION PURSUANT TO18 U.S.C SECTION 1350AS ADOPTED PURSUANT TO




SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002










In connection with the quarterly report on Form 10-Q of Crater Mountain Resources, Inc. (the “Company”) for the period ended September 30, 2010, as filed with the Securities and Exchange Commission on the date hereof (the




“Report”), I, Roger Renken, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:






a) The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and






b) The information contained in the report fairly presents, in all material aspects, the financial condition and results of operations of the Company.






Dated:  May 17, 2011






CRATER MOUNTAIN RESOURCES, INC., Registrant




/s/ Roger Renken


By: Roger Renken, Chief Executive Officer and Chief Financial Officer
| 1.   | The Report fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and |
|----------------|--------------------------------------------------------------------------------------------------------------|

| 2.   | The information contained in the Report fairly presents, in all material respects, the consolidated financial condition of the Company as of the dates presented and the consolidated result of operations of the Company for the periods presented. |
|----------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  By:    |  /s/ Marco Bastidas                                                   |
|--------------|----------------------------------------------------------------------------|
|  Name:  |  Marco Bastidas                                                       |
|  Title: |  Principal Executive Officer,Principal Financial Officer and Director |
|  Date:  |  February 16, 2010                                                    |
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6029 Engrossed in House (EH)]

<DOC>
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
115th CONGRESS
  2d Session
                                H. R. 6029

_______________________________________________________________________

                                 AN ACT

 
  To amend the Omnibus Crime Control and Safe Streets Act of 1968 to 
reauthorize the comprehensive opioid abuse grant program, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Reauthorizing and Extending Grants 
for Recovery from Opioid Use Programs Act of 2018'' or the ``REGROUP 
Act of 2018''.

SEC. 2. REAUTHORIZATION OF THE COMPREHENSIVE OPIOID ABUSE GRANT 
              PROGRAM.

    Section 1001(a)(27) of the Omnibus Crime Control and Safe Streets 
Act of 1968 (34 U.S.C. 10261(a)(27)) is amended by striking ``through 
2021'' and inserting ``and 2018, and $330,000,000 for each of fiscal 
years 2019 through 2023''.

            Passed the House of Representatives June 13, 2018.

            Attest:

                                                                 Clerk.
115th CONGRESS

  2d Session

                               H. R. 6029

_______________________________________________________________________

                                 AN ACT

  To amend the Omnibus Crime Control and Safe Streets Act of 1968 to 
reauthorize the comprehensive opioid abuse grant program, and for other 
                               purposes.
```
----

----

| •                                                 | honest and ethical conduct, including the ethical handling of actual or apparent conflicts of interest between personal and professional relationships;                                                                                           |
|---------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|                                                    |
|         • | full, fair, accurate, timely and understandable disclosure in reports and documents that a registrant files with, or submits to, the Securities and Exchange Commission (“SEC”) and in other public communications made by the Funds; |
|                                                    |
|         • | compliance with applicable laws and governmental rules and regulations;                                                                                                                                                                           |
|                                                    |
|         • | the prompt internal reporting of violations of the Code to an appropriate person or persons identified in the Code; and                                                                                                                           |
|                                                    |
|         • | accountability for adherence to the Code.                                                                                                                                                                                                         |

----

----
EXHIBIT 32.2

CERTIFICATION PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of
CurrencySharesSMSouth African Rand Trust (the
Trust) on Form 10-Q for the period ended April 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Joseph Arruda, Chief Financial Officer of Rydex Specialized Products LLC,
the Sponsor of the Trust, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust.



|                             
|-----------------------------
|Date: June 9, 2010           
|                             
|/s/ Joseph Arruda            
|Joseph
Arruda*               
|Chief Financial Officer      
|(principal financial officer)



|* | The Registrant is
a trust and Joseph Arruda is signing in his capacity as the principal financial officer of Rydex Specialized Products LLC, the Sponsor of the Registrant.
|- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Exhibit 31.1
 CERTIFICATION PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
      a)
    
    Designed such disclosure controls and procedures, or caused such disclosure controls and
procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its condensed consolidated subsidiaries, is made known
to us by others within those entities, particularly during the period in which this
quarterly report is being prepared;b)
    
    Designed such internal control over financial reporting, or caused such internal control
over financial reporting to be designed under our supervision, to provide reasonable
assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with generally accepted accounting
principles;c)
    
    Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report, based on such
evaluation; andd)
    
    Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the registrants
fourth fiscal quarter in the case of the annual report) that has materially affected, or is
reasonably likely to materially affect, the registrants internal controls over financial
reporting; and
  a)
    
    All significant deficiencies and material weaknesses in the design or operation of
internal controls over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information; andb)
    
    Any fraud, whether or not material, that involves management or other employees who have
a significant role in the registrants internal controls over financial reporting.
 Date: May 15, 2009
    By:
    /s/ KI NAMKI NAMChairman of the Board and Chief Executive Officer
AGENDA 

Advisory Board on Radiation and Worker Health – Meeting 139

Videoconference:

Join ZoomGov Meeting 

https://cdc.zoomgov.com/j/1609616536?pwd=eUZGYkhONGJnMzVwWmcvSkNaNmowZz09

Meeting ID: 160 961 6536

Passcode: 48605170

Teleconference:

Phone: (646) 828-7666 (U.S. East Coast); (669) 254-5252 (U.S. West Coast)

Meeting ID: 160 961 6536

Participants ID: #

Meeting Password: 48605170

NOTE: All times in Eastern Time

Wednesday, April 14, 2021 

1:00 p.m. – 1:15 p.m. Welcome (Designate), Chair

1:15 p.m. – 1:30 p.m. NIOSH Program Update Mr. Grady Calhoun, NIOSH

1:30 p.m. – 1:45 p.m. DOL Program Update Mr. Frank (Chris) Crawford,

DOL

1:45 p.m. – 2:00 p.m. DOE Program Update Mr. Greg Lewis, DOE

2:00 p.m. – 3:15 p.m. Procedures Review

Finalization/Approval Process

Ms. Josie Beach, Chair,

Subcommittee on 

Procedures Review

Ms. Kathleen Behling, 

SC&A

3:15 p.m. – 3:45 p.m. Subcommittee on Dose 

Reconstruction Reviews 

Update 

Dr. David Kotelchuck, 

Chair, Subcommittee on 

Dose Reconstruction 

Reviews

3:45 p.m. – 4:00 p.m. Break
4:00 p.m. – 5:15 p.m. Board Work Session (Designate), Chair

5:15 p.m. – 6:15 p.m. * Public Comment

Adjourn

Thursday, April 15, 2021 

1:00 p.m. – 1:15 p.m. Welcome (Designate), Chair

1:15 p.m. – 1:30 p.m. SEC Petitions Status Update Mr. Chuck Nelson, NIOSH

1:30 p.m. – Savannah River Site SEC 

Petition 103 (Aiken, South 

Carolina; October 1972 – 

2007) PV

Mr. Brad Clawson, Chair, 

SRS Work Group 

Dr. Tim Taulbee, NIOSH

Mr. Joe Fitzgerald, SC&A 

SEC Petitioner(s): ***

Adjourn

* Public comment period will conclude at 6:15 p.m. or following the final call for public comment, 

whichever comes first. If you plan to comment, please be prepared to comment at 5:15 p.m.
[Federal Register Volume 75, Number 81 (Wednesday, April 28, 2010)]
[Presidential Documents]
[Page 22203]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-10037]




                        Presidential Documents 



Federal Register / Vol. 75 , No. 81 / Wednesday, April 28, 2010 / 
Presidential Documents

___________________________________________________________________

Title 3--
The President

[[Page 22203]]

                Memorandum of April 20, 2010

                
Delegation of Certain Functions Under Section 
                1265 of the National Defense Authorization Act for 
                Fiscal Year 2010

                Memorandum for the Secretary of State

                By the authority vested in me as President by the 
                Constitution and the laws of the United States, 
                including section 301 of title 3, United States Code, I 
                hereby delegate to you the functions and authority 
                conferred upon the President by section 1265 of the 
                National Defense Authorization Act for Fiscal Year 
                2010, Public Law 111-84, to make the specified report 
                to the Congress.

                You are authorized and directed to notify the 
                appropriate congressional committees and publish this 
                memorandum in the Federal Register. 
                <GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
                
                    (Presidential Sig.)

                THE WHITE HOUSE,

                    Washington, April 20, 2010

[FR Doc. 2010-10037
Filed 4-27-10; 8:45 am]
Billing code 4710-10-P
EXHIBIT 99.9
                                                                  ------------


                               LETTER OF CONSENT

TO:      United States Securities and Exchange Commission

RE:      ARC ENERGY TRUST - ANNUAL REPORT ON FORM 40-F

We hereby  consent to the use and  reference  to our name and our report dated
February 23, 2006  evaluating  ARC Energy  Trust's  petroleum  and natural gas
reserves as at December  31, 2005,  as described in the Annual  Report on Form
40-F of ARC Energy  Trust for the fiscal  year ended  December  31, 2005 filed
with the United  States  Securities  and Exchange  Commission  pursuant to the
SECURITIES EXCHANGE ACT OF 1934, as amended, and the inclusions of information
derived from our report.

                                               Sincerely,

                                               GLJ PETROLEUM CONSULTANTS LTD.

                                               /s/ James H. Willmon, P.Eng.
                                               ------------------------------
                                               James H. Willmon, P. Eng.
                                               Vice-President


Calgary, Alberta
Date:  March 29, 2006